LABORATORY RESEARCH RAC1 GTPase Promotes the Survival of Breast Cancer Cells in Response to Hyper-Fractionated Radiation Treatment The authors investigated the effect of Rac1 on the survival of breast cancer cells treated with hyper-fractionated radiation, which is used clinically for cancer treatment. [Oncogene] Abstract The C/EBPδ Protein Is Stabilized by Estrogen Receptor α Activity, Inhibits SNAI2 Expression and Associates with Good Prognosis in Breast Cancer Scientists report a different role for Ccaat/enhancer-binding protein δ (C/EBPδ, CEBPD) in breast cancer. They found that the C/EBPδ protein is expressed in normal breast epithelial cells and in low-grade cancers. [Oncogene] Abstract CAP1 (Cyclase-Associated Protein 1) Exerts Distinct Functions in the Proliferation and Metastatic Potential of Breast Cancer Cells Mediated by ERK Scientists found that CAP1 exerts cell type-dependent functions in the invasiveness of breast cancer cells. Depletion of CAP1 in the metastatic MDA-MB-231 and BT-549 cancer cells stimulated the metastatic potential while it actually inhibited it in the non-metastatic MCF-7 cancer cells or in normal cells. [Sci Rep] Full Article Slug-Upregulated miR-221 Promotes Breast Cancer Progression through Suppressing E-Cadherin Expression Researchers reveal a novel mechanism that E-cadherin is post-transcriptionally regulated by Slug-promoted miR-221, which serves as an additional blocker for E-cadherin expression in metastatic tumor cells. [Sci Rep] Full Article CD24 Cell Surface Expression in Mvt1 Mammary Cancer Cells Serves as a Biomarker for Sensitivity to Anti-IGF1R Therapy The authors demonstrated that downregulation of the insulin-like growth factor receptor (IGF1R) specifically in cancer cells expressing CD24 on the cell surface membrane affect both their morphology (from mesenchymal-like into epithelial-like morphology) and phenotype in vitro. [Breast Cancer Res] Full Article Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via HIF-1α Investigators found that breast cancer cells exposed to sustained growth factor heregulin treatment show markedly enhanced Rac1 activation and migratory activity in response to the CXCR4 ligand SDF-1/CXCL12, effects mediated by P-Rex1, a Rac-GEF aberrantly expressed in breast cancer. [Mol Cell Biol] Abstract Janus Kinase 1 Is Essential for Inflammatory Cytokine Signaling and Mammary Gland Remodeling Using a novel mammary gland-specific JAK1 knockout model, researchers demonstrated that this tyrosine kinase is essential for the activation of STAT1, STAT3, and STAT6 in the mammary epithelium. [Mol Cell Biol] Abstract CLINICAL RESEARCH Neoadjuvant Sequential Docetaxel followed by High-Dose Epirubicin in Combination with Cyclophosphamide Administered Concurrently with Trastuzumab: The DECT Trial Investigators report the results of the DECT trial, a Phase II study of locally advanced or operable HER2-positive breast cancer treated with taxanes and concurrent anthracyclines and trastuzumab. [J Cell Physiol] Abstract Deficiency of Mitochondrial Modulator MCJ Promotes Chemoresistance in Breast Cancer Methylation-controlled J protein (MCJ, also known as DNAJC15) is a negative regulator of mitochondrial respiration and has been associated with chemotherapeutic drug sensitivity in cancer cell lines. Investigators showed, in a retrospective study of a large cohort of breast cancer patients, that low MCJ expression in breast tumors predicts high risk of relapse in patients treated with chemotherapy; however, MCJ expression did not correlate with response to endocrine therapy. [JCI Insight] Full Article | Press Release |